Epharmix Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Epharmix

Access the complete profile.

Epharmix Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	334510 Electromedical & Electrotherapeutic Apparatus Manufacturing
Address	4220 Duncan Ave Saint Louis, MO 63110

Note: Revenues for privately held companies are statistical evaluations.


Epharmix's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Epharmix's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Epharmix is classified as operating in the Electromedical & Electrotherapeutic Apparatus Manufacturing industry, NAICS Code 334510.

Epharmix Annual Revenue and Growth Rate

Epharmix	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Epharmix's revenues are gauged from an analysis of company filings.

Epharmix's Income Statement (based on Industry Averages)

Epharmix P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Epharmix is developing and marketing. Epharmix doesn't have any recent trademark applications, indicating Epharmix is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
DEVICELESS RPM Provision of short message service (SMS) transmission services in the field of patient healthcare monitoring to drive improved outcomes; provision of short message service (SMS) transmission services in the nature of providing an SMS-based messaging service with condition-specific dialogues for enabling healthcare professionals to communicate with patients or caregivers for determining when to initiate medical interventions; technology-enabled services in the field of patient healthcare monitoring in the nature of wireless electronic transmission of messages through interactive push notifications, resulting in a direct text or audio message to the mobile device enabled by software for mobile messaging systems	07/10/2020
DEVICELESS REMOTE PATIENT MONITORING Provision of short message service (SMS) transmission services in the field of patient healthcare monitoring to drive improved outcomes; provision of short message service (SMS) transmission services in the nature of providing an SMS-based messaging service with condition-specific dialogues for enabling healthcare professionals to communicate with patients or caregivers for determining when to initiate medical interventions; technology-enabled services in the field of patient healthcare monitoring in the nature of wireless electronic transmission of messages through interactive push notifications, resulting in a direct text or audio message to the mobile device enabled by software for mobile messaging systems	07/10/2020
CARESIGNAL Provision of short message service (SMS) transmission services in the field of patient healthcare monitoring to drive improved outcomes; provision of short message service (SMS) transmission services in the nature of providing an SMS-based messaging service with condition-specific dialogues for enabling healthcare professionals to communicate with patients or caregivers for determining when to initiate medical interventions; technology-enabled services in the field of patient healthcare monitoring in the nature of wireless electronic transmission of messages through interactive push notifications, resulting in a direct text or audio message to the mobile device enabled by software for mobile messaging systems	08/28/2019

See all trademarks and details in the Full Report.

Market Share of Epharmix's Largest Competitors

A competitive analysis shows these companies are in the same general field as Epharmix, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
VERISK ANALYTICS	Jersey City, NJ	100
WATERS	Milford, MA	91
KONGSBERG MARITIME	Houston, TX	9
HLT HOLDING	Fort Worth, TX	8
SANDELIUS INSTRUMENTS	Houston, TX	8
LINK GROUP	Plymouth, MI	7
TESCO ENTERPRISES	Sacramento, CA	7
BARDY DIAGNOSTICS	Bellevue, WA	6
VERSATECH AUTOMATION SERVICES	Houston, TX	4

Nearby Competitors

These companies are similar in business line and location to Epharmix. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
STEREOTAXIS	Saint Louis, MO	100
BECS TECHNOLOGY	Saint Louis, MO	92
CR MAGNETICS	Saint Louis, MO	21
EPHARMIX	Saint Louis, MO	15
EWR RADAR SYSTEMS	Saint Louis, MO	12
UNANDUP	Saint Louis, MO	5

Other Companies at 4220 Duncan Ave, Saint Louis MO

Company	Headquarters	Revenue ($ MM)
COVENE	St Louis, MO	100
UNANDUP	Saint Louis, MO	63
CYBERUP	Saint Louis, MO	0
DREAM BUILDERS 4 EQUITY	Saint Louis, MO	0
ST. LOUIS QUEER PLUS SUPPORT HELPLINE	St. Louis, MO	0

Future Competition: Epharmix's Fastest Growing Competitors

These companies are in the same general field as Epharmix and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)